Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) EBITDA Margin (2016 - 2025)

AtriCure (ATRC) has disclosed EBITDA Margin for 16 consecutive years, with 1.24% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 1449.0% to 1.24% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.84% through Dec 2025, up 777.0% year-over-year, with the annual reading at 1.84% for FY2025, 777.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 1.24% at AtriCure, up from 0.33% in the prior quarter.
  • The five-year high for EBITDA Margin was 137.64% in Q3 2021, with the low at 29.1% in Q1 2021.
  • Average EBITDA Margin over 5 years is 3.45%, with a median of 7.42% recorded in 2023.
  • The sharpest move saw EBITDA Margin surged 14640bps in 2021, then crashed -15353bps in 2022.
  • Over 5 years, EBITDA Margin stood at 19.77% in 2021, then skyrocketed by 83bps to 3.38% in 2022, then crashed by -139bps to 8.07% in 2023, then crashed by -64bps to 13.24% in 2024, then soared by 109bps to 1.24% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 1.24%, 0.33%, and 3.83% for Q4 2025, Q3 2025, and Q2 2025 respectively.